Re: Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer

J Natl Cancer Inst. 2001 Feb 7;93(3):240-1. doi: 10.1093/jnci/93.3.240.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticarcinogenic Agents / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / chemistry
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Breast Neoplasms / prevention & control*
  • Female
  • Fenretinide / therapeutic use*
  • Humans
  • Menopause
  • Neoplasms, Second Primary / prevention & control*
  • Proportional Hazards Models
  • Randomized Controlled Trials as Topic
  • Receptors, Estrogen / analysis
  • Receptors, Progesterone / analysis
  • Risk Factors
  • Treatment Outcome

Substances

  • Anticarcinogenic Agents
  • Antineoplastic Agents
  • Receptors, Estrogen
  • Receptors, Progesterone
  • Fenretinide